Pharmacokinetic comparison of puerarin after oral administration of Jiawei-Xiaoyao-San to healthy volunteers and patients with functional dyspepsia: influence of disease state

被引:0
|
作者
Qin, Feng [1 ,2 ]
Huang, Xi [1 ,2 ,3 ]
Zhang, Hong-Min [3 ,4 ]
Ren, Ping [1 ,2 ]
机构
[1] Cent S Univ, Xiangya Hosp, Lab Ethnopharmacol, Changsha 410008, Hunan, Peoples R China
[2] Cent S Univ, Xiangya Hosp, Dept Integrated Chinese & Western Med, Changsha 410008, Hunan, Peoples R China
[3] Sichuan Univ, W China Hosp, Lab Ethnopharmacol, Chengdu 610064, Peoples R China
[4] Henan Prov Hosp, Inst Ophthalmol, Zhengzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
functional dyspepsia; Jiawei-Xiaoyao-San; pharmacokinetics; puerarin; PERFORMANCE LIQUID-CHROMATOGRAPHY; PLASMA; PREVALENCE; ISOFLAVONE; SYMPTOMS; HPLC;
D O I
10.1211/jpp/61.01.0018
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives An investigation has been designed and conducted to compare the pharmacokinetics of puerarin after oral administration of Jiawei-Xiaoyao-San to healthy Volunteers and to patients with functional dyspepsia. Methods Quantification of puerarin in serum was achieved using a simple and rapid HPLC method for pharmacokinetic study. Key findings After oral administration of decoctions of Jiawei-Xiaoyao-San to healthy volunteers and patients with functional dyspepsia, Puerarin was absorbed and reached it maximum concentration of 56.47 +/- 15.60 and 29.40 +/- 8.89 ng/ml at 51.00 +/- 8.22 and 50.00 +/- 12.25 min, respectively. Compared with the value of AUC(0-360) (5.55 +/- 1.47 mu g/ml min) in healthy volunteers', a smaller value of AUC(0-360)) (3.35 +/- 1.17 mu g/ml min) was observed in patients with functional dyspepsia. Conclusions There were statistically significant differences in the pharmacokinetic parameters of puerarin including the values for C-max, AUC(0-360), Cl/F and MRT0-360 between healthy volunteers and patients with functional dyspepsia, The pharmacokinetic parameters showed that functional dyspepsia reduced the absorption Of puerarin after oral administration of Jiawei-Xiaoyao-San.
引用
收藏
页码:125 / 129
页数:5
相关论文
共 8 条
  • [1] Pharmacokinetic comparison of ferulic acid in healthy volunteers and patients with functional dyspepsia following oral administration of Chaihu-Shugan-San
    Qiu, Xin-Jian
    Huang, Xi
    Chen, Ze-Qi
    Ren, Ping
    Huang, Wei
    Qin, Feng
    Hu, Si-Hang
    Huang, Jun
    He, Juan
    Liu, Zhao-Qian
    Zhou, Hong-Hao
    JOURNAL OF MEDICINAL PLANTS RESEARCH, 2011, 5 (07): : 1230 - 1237
  • [2] Tolerability and Pharmacokinetic Comparison of Oral, Intramuscular, and Intravenous Administration of Levosulpiride After Single and Multiple Dosing in Healthy Chinese Volunteers
    Xu, Mingzhen
    Zhou, Ying
    Ni, Yang
    He, Xiaomeng
    Li, Huqun
    Sattar, Haseeb
    Chen, Hui
    Li, Weiyong
    CLINICAL THERAPEUTICS, 2015, 37 (11) : 2458 - 2467
  • [3] Pharmacokinetic study of the prokinetic compounds meranzin hydrate and ferulic acid following oral administration of Chaihu-Shugan-San to patients with functional dyspepsia
    Qiu, Xin-Jian
    Huang, Xi
    Chen, Ze-Qi
    Ren, Ping
    Huang, Wei
    Qin, Feng
    Hu, Si-Hang
    Huang, Jun
    He, Juan
    Liu, Zhao-Qian
    Zhou, Hong-Hao
    JOURNAL OF ETHNOPHARMACOLOGY, 2011, 137 (01) : 205 - 213
  • [4] Pharmacokinetic study of the prokinetic ABCs liquiritigenin, naringenin and hesperitin following the oral administration of Si-Ni-San decoction to functional dyspepsia patients
    Huang, Xi
    Xu, Jianjun
    He, Juan
    Shi, Shaoqi
    Yan, Hongbin
    Wang, Jian
    Ren, Ping
    XENOBIOTICA, 2019, 49 (06) : 708 - 717
  • [5] PLASMA-CONCENTRATIONS OF DILTIAZEM AFTER ORAL-ADMINISTRATION IN CORONARY-ARTERY DISEASE PATIENTS - A COMPARISON WITH THOSE IN NORMAL VOLUNTEERS
    KOIWAYA, Y
    MATSUGUCHI, T
    NAKAMURA, M
    ETOH, A
    CLINICAL THERAPEUTICS, 1981, 4 (02) : 127 - 132
  • [6] Pharmacokinetics and evaluation of systemic side effects of budesonide after oral administration of modified release capsules in healthy volunteers, ileostoma patients and patients with Crohn's disease.
    Moellmann, HW
    Hochhaus, G
    Tromm, A
    Moellmann, A
    Derendorf, H
    Barth, J
    Froehlich, P
    Ecker, KW
    Lindemann, A
    GASTROENTEROLOGY, 1996, 110 (04) : A972 - A972
  • [7] Physiologically based pharmacokinetic modelling of treprostinil after intravenous injection and extended-release oral tablet administration in healthy volunteers: An extrapolation to other patient populations including patients with hepatic impairment
    Wu, Xuemei
    Zhang, Xiaohan
    Xu, Ruichao
    Shaik, Imam Hussain
    Venkataramanan, Raman
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (02) : 587 - 599
  • [8] Computational Predictions of Mycophenolic Acid Exposure after Oral Administration using a Joined In Vitro-In Vivo Extrapolation and Physiologically-Based Pharmacokinetic Modeling Approach in Caucasian and Chinese Healthy Volunteers and Patients With Varying Degree of Renal Impairment
    Joshi, Rujuta
    Venkataramanan, Raman
    Kalluri, Hari Varun
    TRANSPLANTATION, 2017, 101 (05) : S13 - S14